A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours

BJU International

Volumn 92, Issue 1, 2003, Pages 32-35

  Atsu N ^a   Eskicorapci S ^a   Uner A ^a   Ekici, S ^a   Gungen Y ^a   Erkan, I ^a   Uygur, M Cemil ^a,b   Ozen H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Nonseminomatous; Stage I; Surveillance; Testicular tumours

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; PLATINUM;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EMBRYONAL CARCINOMA; FOLLOW UP; HUMAN; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TESTIS TUMOR; YOLK SAC TUMOR;

ADOLESCENT; ADULT; CLINICAL PROTOCOLS; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 0037586512     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04270.x     Document Type: Article

References (21)

1. Nichols CR, Timmermann R, Foster RS et al. Neoplasms of the testis. In Holland JF, Bast RC Jr, Morton DL, Frei E III, Kufe DW, Weichselbaum RR eds, Cancer Medicine. Vol. 2 chapt 140. Baltimore: Williams & Wilkins, 1997: 2177-211
2. Read G, Stenning SP, Cullen MH et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 1992; 10: 1762-8
3. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Stage I nonseminomatous germ-cell testicular cancer-management options and risk-benefit considerations. World J Urol 1994; 12: 170-6
4. Sharir S, Jewett M, Sturgeon J et al. Progression detection of stage I nonseminomatous testis cancer on surveillance: Implications for the follow up protocol. J Urol 1999; 161: 472-6
5. Peckham MJ, Barrett A, Husband JE, Hendry WF. Orchiectomy alone in testicular stage I nonseminomatous germ cell tumors. Lancet 1982; 2: 678-80
6. Hao D, Seidel J, Brant R et al. Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol 1998; 160: 768-71
7. Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ. Prognostic factors in stage I nonseminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: Implications for adjuvant chemotherapy. J Clin Oncol 1986; 4: 1031-6
8. Gels ME, Hoekstra HJ, Sleijfer DT et al. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ-cell tumors and consequences for further follow-up: a single center 10-year experience. J Clin Oncol 1995; 13: 1188-94
9. Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999; 161: 1148-52
10. Böhlen D, Burkhard FC, Mills R, Sonntag RW, Studer UE. Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for high-risk germ cell cancer. J Urol 2001; 165: 441-4
11. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-89. Br J Urol 1993; 71: 326-35
12. Sternberg CN, Bosl GJ. Advances in testicular cancer. Role of chemotherapy Prog Clin Biol Res 1988; 277: 79-84
13. Colls BM, Harvey V, Skelton L et al. Results of the surveillance policy of stage I nonseminomatous germ cell testicular tumours. Br J Urol 1992; 70: 423-8
14. Freedman LS, Parkinson MC, Jones WG et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987; 2: 294-8
15. Sturgeon JFG, Jewett MAS, Alison RE et al. Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol 1992; 10: 564-8
16. Tekgül S, Özen H, Özgü I, Sahin A, Ergen A, Remzi D. Surveillance only policy in clinical stage I non-seminomatous germ cell tumors of the testis. Bull Cancer 1995; 82: 162-6
17. Pont J, Holtl W, Kosak D. Risk adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J Clin Oncol 1990; 8: 16-20
18. Alexandre J, Fizazi K, Mahe C et al. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgruoup of patients with a very low risk of relapse. Eur J Cancer 2001; 37: 576-82
19. Stiggelbout AM, Kiebert GM, Haes J. Surveillance versus adjuvant chemotherapy in stage I nonseminomatous testis cancer. Eur J Cancer 1996; 13: 2267-74
20. David BL, Bruce AL. A rationale approach to managing stage I nonseminomatous testicular germ cell cancer. Urol Clin North Am 1998; 25: 405-23
21. Boyer JM, Cox K, Tatersall M, Findlay M, Grygiel J, Rogers J. Active surveillance after orchidectomy for nonseminomatous testicular germ cell tumors: Late relapse may occur. Urology 1997; 50: 588-92